logo
Search orAI Icon𝛼SK
ENTITY

Immix Biopharma Inc (IMMX US)

39
Analysis
Health Care • United States
Immix Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel class of tissue-specific therapeutics in oncology and inflammation to treat inflammatory bowel disease, including ulcerative colitis and crohn's diseases. Immix Biopharma serves customers in the United States.
more
Company Event • 26 Mar 2026 04:00 • Upcoming
Add To Calendar

Q4 2025

Company Event • 08 Nov 2025 05:00 • Upcoming
Add To Calendar

Q3 2025

Company Event • 08 Aug 2025 19:00 • Upcoming
Add To Calendar

Q2 2025

Company Event • 30 Jun 2025 19:00 • Upcoming
Add To Calendar

Corporate Presentation

Company Event • 04 Jun 2025 03:00 • Latest

Status Update

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x